Blue Earth Diagnostics
Clinical trials sponsored by Blue Earth Diagnostics, explained in plain language.
-
Head-to-Head scan test aims to sharpen prostate cancer detection
Diagnosis CompletedThis study directly compared two similar imaging scans (PET scans) in the same patients to see if one was better at finding returning prostate cancer. It involved 55 men whose prostate cancer had returned after surgery, but their PSA blood levels were still very low. The main goa…
Phase: PHASE4 • Sponsor: Blue Earth Diagnostics • Aim: Diagnosis
Last updated Mar 27, 2026 12:40 UTC
-
New scan aims to pinpoint hidden prostate cancer comeback
Diagnosis CompletedThis study tested a new type of PET scan designed to find prostate cancer that has returned after initial treatment. It involved 391 men whose blood tests showed rising PSA levels, suggesting the cancer might be back. The main goal was to see how accurately and safely this new sc…
Phase: PHASE3 • Sponsor: Blue Earth Diagnostics • Aim: Diagnosis
Last updated Mar 25, 2026 14:07 UTC
-
New scan tested to better see prostate cancer
Diagnosis CompletedThis early-stage study tested a new imaging agent called rhPSMA-7.3 (18F) injection. The main goals were to check its safety, see how it moves through the body, and understand how well it can create pictures of prostate cancer. The study involved a small group of healthy voluntee…
Phase: PHASE1 • Sponsor: Blue Earth Diagnostics • Aim: Diagnosis
Last updated Mar 23, 2026 15:17 UTC